Regeneron Plans Human Trials of Drug to Prevent, Treat Covid-19
05 May 2020 - 9:32PM
Dow Jones News
By Dieter Holger
Regeneron Pharmaceuticals Inc. said human trials of a new
Covid-19 drug are slated to begin in summer.
The Eastview, N.Y.-based drugmaker said its novel antibody
cocktail, REGN-COV2, could be used to prevent and treat Covid-19
and will enter human trials in June, said Leonard Schleifer, chief
executive at Regeneron.
"We are working in parallel to have large-scale quantities
available by late summer," Mr. Schleifer said in a press
release.
Write to Dieter Holger at dieter.holger@wsj.com;
@dieterholger
(END) Dow Jones Newswires
May 05, 2020 07:17 ET (11:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jul 2023 to Jul 2024
